AcelRx Pharmaceuticals (ACRX) Stock: Gains On Application Acceptance

AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) AcelRx Pharmaceuticals is having a great start to today’s trading session. At the opening bell, the stock was already trading in the green. When the market opened, we saw a slight correction before gains continued. Nonetheless, the stock continues to head upward in a big way. Below, we’ll talk about … Read more

Today In Biotech: MannKind Corporation (MNKD) | AcelRx Pharmaceuticals (ACRX) | LaJolla Pharmaceutical Company (LJPC) | Gilead Sciences (GILD)

MannKind Stock Falls On Piper Jaffray Downgrade MannKind Corporation (NASDAQ: MNKD) MannKind is having a rough day in the market today after Piper Jaffray downgraded the stock from a “Neutral” rating to an “Underweight” rating. According to Piper Jaffray, the reason for the decline surrounds new opinions of Afrezza. However, I think they missed this … Read more

AcelRx Pharmaceuticals (ACRX) Completes Re-Submission Talks With FDA

AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) AcelRx Pharmaceuticals is having a rough day in the market today after the company disclosed information with regard to recent talks with the United States Food and Drug Administration. Today, we’ll take a look at the result of the talks, how ACRX reacted to the news, and what we can … Read more